Skin Autofluorescence as a Measure of Advanced Glycation End Products Deposition Is Elevated in Peripheral Artery Disease | Zendy

Lisanne C. de Vos | Zendy; Marjon J. Noordzij | Zendy; Douwe J. Mulder | Zendy; Andries J. Smit | Zendy; Helen L. Lutgers | Zendy; Robin P. F. Dullaart | Zendy; Pieter W. Kamphuisen | Zendy; Clark J. Zeebregts | Zendy; Joop D. Lefrandt | Zendy

Open Access

Skin Autofluorescence as a Measure of Advanced Glycation End Products Deposition Is Elevated in Peripheral Artery Disease

Author(s) -

Lisanne C. de Vos,

Marjon J. Noordzij,

Douwe J. Mulder,

Andries J. Smit,

Helen L. Lutgers,

Robin P. F. Dullaart,

Pieter W. Kamphuisen,

Clark J. Zeebregts,

Joop D. Lefrandt

Publication year - 2012

Publication title -

arteriosclerosis thrombosis and vascular biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.007

H-Index - 270

eISSN - 1524-4636

pISSN - 1079-5642

DOI - 10.1161/atvbaha.112.300016

Subject(s) - medicine , diabetes mellitus , comorbidity , coronary artery disease , odds ratio , kidney disease , cardiology , confounding , vascular disease , confidence interval , abdominal aortic aneurysm , surgery , aneurysm , endocrinology

Evidence for an important role of advanced glycation end products (AGEs) in the development of atherosclerosis and cardiovascular disease beyond diabetes mellitus and renal disease is growing. Skin autofluorescence (SAF) is a validated noninvasive measure of tissue AGEs. We hypothesized that SAF is elevated in peripheral artery disease (PAD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research